# Flomoxef

## Flumarin inj 1 gm

| 藥物代碼 | IFMR |
| :--- | :--- |
| 適應症 | Flomoxef sodium susceptible strains of Staphylococcus sp., Streptococcus sp., Pneumococcus sp., Neisseria gonorrhoeae, Moraxella \(Branhamella\) catarrhalis, Escherichia coli, Klebsiella sp., Proteus sp., Morganella morganii, Providencia sp., Haemophilus influenzae, Peptostreptococcus sp., Bacteroides sp., Prevotella sp. \(excluding Prevotella bivia\) |
| 副作用 | Rash, Anemia \(decreased RBC, decreased hemoglobin, decreased hematocrit\), eosinophilia, granulocytopenia, Increased SGOT\(AST\), increased SGPT \(ALT\), increased Al-P, increased gamma-GTP, Diarrhea, |
| 禁忌 | Patients with a history of shock following exposure to any of the ingredients in this product.RELATIVE CONTRAINDICATIONS: Patients with a history of hypersensitivity to any of the ingredients in this product or to other cephalosporin antibioticsCareful Administration: Patients with a history of hypersensitivity to penicillins. Patients with a personal or familial predisposition to allergic reactions such as bronchial asthma, rash and urticaria. Patients with severe renal dysfunction. Patients of poor oral ingestion, patients receiving parenteral feeding, or patients in poor general condition. Elderly patients. |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | N/A |
| 附帶說明 | \[仿單\]關於懷孕期投予的安全性尚未確立, 孕婦或有可能懷孕的婦人,在治療上判斷其有益性高於危險性時才能投與 |
| 哺乳期用藥建議 | Unknown 尚未建立 |
| 附帶說明 | \[仿單\]關於懷孕期投予的安全性尚未確立, 孕婦或有可能懷孕的婦人,在治療上判斷其有益性高於危險性時才能投與 |
| 注射劑給藥建議途徑 | IVD, IVPUSH |
| 乾粉稀釋液 | 1g的vial包裝,以4mL以上的注射用水,5%葡萄糖注射液,或生理食鹽水加入後溶解. |
| 輸注點滴液 | 【D5W】 可選  【N/S】 可選 |
| IVP 用法建議 | 仿單無IVPUSH的相關建議. |
| IVD 用法建議 | 仿單無建議滴注時間,但動力學資料是將藥物以1小時點滴輸注. |
| 注意事項 | 1.調配後室溫可保存6小時,冷藏可保存24小時. 2.仿單無稀釋後安定性資料.2021/1/24廠商提供安定性資料,1g稀釋於5%葡萄糖注射液,或生理食鹽水,100mL或500mL在攝氏25度以下可有6小時安定,冷藏可有24小時安定. |

